Visit us in the Connect Lounge for a free giveaway
vive logo white

Reimagine health,
revolutionize chronic care

Learn how we’re using data-driven insights to optimize interventions, clinical decisions, and population health.

vive benefits circle
*Welldoc Diabetes Rx/OTC is an FDA-cleared medical device (“BlueStar ️”), intended for use by health care providers and their adult patients with type 1 or type 2 diabetes. For full labeling information, visit welldoc.com. The other Welldoc products are non-FDA-cleared and intended to promote general wellness and education/self-management of various chronic disease states.

Anytime, anywhere chronic care

Empower people everywhere to self-manage their chronic conditions.
Enable your health ecosystem to optimize interventions, clinical decisions and population health.

Tailored to individuals. Scalable to populations.

vive landing image 2

Total Care

Encourage self-management of chronic conditions and positive lifestyle changes, while supporting better total health—with an AI-powered digital coaching app.

vive landing image 1

Connected Care

Support care team interventions, inform decision making, and better manage population level health and cost outcomes—with data-driven insights.

vive landing image 4

Evidence-based Care

Invest in technology based on clinical standards, with FDA-cleared capabilities for type 1 and type 2 diabetes.*

vive landing image 3

Care Anywhere

Securely connect health data from 400+ devices and data solutions, while easily integrating within existing care workflows—with a scalable application.

The difference is in the data.

Optimize care, cost, and utilization for multiple chronic conditions and comorbidities with our AI-driven digital health platform.

reduction icon

A1C reduction

Users that enrolled in BlueStar® through a Diabetes Educator at point of care who engaged more than 2.5 times a week had a 1.6% drop in A1C

pressure lowered icon

Blood pressure lowered

Data analysis examined the potential impact of our diabetes solution on hypertension in the first 3 months and saw a 7.4 - 12 mmHg drop in patient blood pressure

glucose control icon

Blood glucose control

77% Controlled blood glucose was observed among consistent app users when in conjunction with medication changes

cost savings icon

Cost savings

On average, app usage led to an annual savings of $3,048 - $3,252 per person with type 2 diabetes

1. Shomali M, Peeples M. Implementation strategy for a digital health tool influences user engagement. Diabetes. 2018;67(Suppl 1):1320-P. doi:10.2337/db18-1320-p
2. Kumbara A, Iyer A, Shomali M. Blood pressure improvement in people using a digital health solution for comprehensive diabetes self-management. Poster presented at: 16th Annual Cardiometabolic Health Congress; October 14-17, 2021; National Harbor, MD.
3. Mudambi M, Crowley K, Dugas M, et al. Consistent engagement with a digital health solution enhances the effect of medication changes on blood glucose control. Poster presented at: Association of Psychological Science, May 2021.
4. IBM Watson Health. Estimating the economic value of a digital therapeutic in type 2 diabetes. Welldoc-sponsored report 2018. Published August 2018.

Learn how Welldoc can empower anytime, anywhere chronic care

References:
1. Shomali M, Peeples M. Implementation strategy for a digital health tool influences user engagement. Diabetes. 2018;67(Suppl 1):1320-P. doi:10.2337/db18-1320-p
2. Kumbara A, Iyer A, Shomali M. Blood pressure improvement in people using a digital health solution for comprehensive diabetes self-management. Poster presented at: 16th Annual Cardiometabolic Health Congress; October 14-17, 2021; National Harbor, MD.
3. Mudambi M, Crowley K, Dugas M, et al. Consistent engagement with a digital health solution enhances the effect of medication changes on blood glucose control. Poster presented at: Association of Psychological Science, May 2021.
4. IBM Watson Health. Estimating the economic value of a digital therapeutic in type 2 diabetes. Welldoc-sponsored report 2018. Published August 2018.

*Welldoc Diabetes Rx/OTC is an FDA-cleared medical device (“BlueStar”), intended for use by health care providers and their adult patients with type 1 or type 2 diabetes. For full labeling information, visit welldoc.com. The other Welldoc products are non-FDA-cleared and intended to promote general wellness and education/self-management of various chronic disease states.
small_c_popup.png

Taking Diabetes Self-Management to the Next Level